Tower Research Capital LLC (Trc) Lexicon Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,155 shares of LXRX stock, worth $8,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,155
Previous 5,971
103.57%
Holding current value
$8,143
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$91.2 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$26.1 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$6.62 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.02 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $126M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...